CXI Healthcare Technology Group Limited

900120KOSDAQFinance

CXI Healthcare Technology Group Limited (900120, KOSDAQ) reported KRW 0bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
202300022Consolidated
202400033Consolidated
202500033Consolidated

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
202310%10.5%99.2%1.7%
202427.2%42.3%99.4%6.3%
202516.9%22.1%99.5%2.5%

Revenue moved -21.2% between 2023 and 2025.

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 17bn
Close priceKRW 1,040
Listed shares16,669,660
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

Workforce — a side measure, not the main one

Employees (2025)26
Women8 (30.8%)
Annual pay, menKRW 203,667
Annual pay, womenKRW 126,500
Pay ratio, women to men62.1%

Other companies in Finance

96 listed companies file under this classification. Showing 12.

See the whole Finance list →